ロード中...
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
OBJECTIVE: During the development of cenobamate, an antiseizure medication (ASM) for focal seizures, three cases of drug reaction with eosinophilia and systemic symptoms (DRESS) occurred. To mitigate the rate of DRESS, a start‐low, go‐slow approach was studied in an ongoing, open‐label, multicenter...
保存先:
| 出版年: | Epilepsia |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317552/ https://ncbi.nlm.nih.gov/pubmed/32396252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16525 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|